Calcium antagonists in cardiovascular disease: Clinical evidence from morbidity and mortality trials;Les inhibiteurs calciques dans les affections cardiovasculaires: Donnees cliniques issues des etudes de morbimortalite

Drugs

Volumn 59, Issue SPEC. ISS. 2, 2000, Pages 25-37

  Oparil, S ^a   Bakir, S E ^a  

^a 1034 Zeigler Research Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AMLODIPINE BESYLATE; ATENOLOL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; HYDROCHLOROTHIAZIDE; LISINOPRIL; NITRENDIPINE; PERINDOPRIL; VERAPAMIL;

AGED; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; REVIEW; TREATMENT OUTCOME;

EID: 0033864395     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200059992-00004     Document Type: Review

References (20)

1. Rationale and design for the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
2. ALLHAT and calcium channel blockers. ALLHAT research group
3. Characteristics of published, ongoing, and planned outcome trials in hypertension
4. The effect of blood pressure reduction on endstage renal disease
5. Rationale, design, and baseline characteristics of the prospective randomized evaluation of the vascular effects of norvasc trial (PREVENT)
6. The anglo-scandinavian cardiac outcome trial (ASCOT)
7. Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: Objectives, protocol, and organization
8. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
9. Subgroup and per-protocol analysis of the randomized European trial on isolated systolic hypertension in the elderly
10. Baseline characteristics of the first 6482 patients enrolled in the CONVINCE study
11. Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial
12. A prospective intervention trial of calcium antagonist therapy in hypertension
13. Isolated systolic hypertension in the elderly
14. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the systolic hypertension in the elderly program (SHEP)
15. Regional differences in attainment of goal blood pressure (BP) among treated hypertensive patients in the United States
16. The antihypertensive and lipid-lowering to prevent heart attack trial
17. Prospective randomized open blinded end-point (PROBE) Study. A novel design for intervention trials. Prospective randomized open blinded endpoint
18. Study population and treatment in the international nifedipine GITS study: Intervention as a goal in hypertension treatment (INSIGHT)
19. Effect of amlodipine on cardiovascular events and procedures
20. Design and baseline characteristics of participants in the African American study of kidney disease and hypertension (AASK) pilot study